Flat-Price vs Dose-Scaling GLP-1 Providers, Compared

Two pricing models, one decision

Every GLP-1 telehealth program uses one of two pricing models. Learn to tell them apart before you enter a card number, because the difference decides what you actually pay over a year — not what the homepage advertises.

A flat-price program charges one monthly amount regardless of your dose. Month one and month twelve cost the same. A dose-scaling (titration-based) program ties price to how much medication you take, so your bill climbs as you move up the standard dose ladder. Both can look cheap at signup, because signup is the lowest dose. That is the trap. This guide is educational only and not medical advice.

Why dose-scaling bites during titration

GLP-1 medications are meant to be increased gradually. You start low to limit nausea, then step up over months toward a maintenance dose. That is the design of the drugs, and it is exactly where dose-scaling pricing turns against you: the same schedule that manages side effects also walks your bill upward, month after month, right when you are least able to judge whether the higher price is worth it.

The clinical results that make these drugs worth taking were measured at full maintenance doses, not the starter dose you pay the introductory price for. Semaglutide produced roughly 15% average body-weight loss in the STEP 1 trial¹, and tirzepatide reached about 20% at its higher doses in SURMOUNT-1². To get near those figures you climb the ladder — and under dose-scaling, climbing the ladder is the same act as raising your monthly cost.

Which providers use which model

Here is the field, split by model. Prices are the figures each provider disclosed at our last review, cheapest first within each group; every one of them can change, so confirm on the provider's own site before you decide. The point of reading it this way is that the model column tells you more about your twelve-month total than the dollar figure next to it does.

One nuance the two columns cannot show: a price can be flat at every dose and still change with the cadence you pick. Nouri holds one price at any dose, but that price is $175 month-to-month and $120 only if you prepay six months — so it belongs in both halves of this page at once.

Flat — one price at every dose:

Tiered, dose-scaling, or intro-only — the number moves:

Three providers in the second table do not publish the maintenance-dose or ongoing price at all — Telos Rx, Strut Health and CareBareRX, whose own FAQ says only that "price varies by dose and medication prescribed". That is the tell. A program confident its number will not move has no reason to hide the number you will actually be paying in month twelve.

SynergyRx is a fourth shape worth naming, because it looks like transparency and is not quite. It posts a price for every product it sells — seven of them, compounded and brand — but no price for every dose. Each figure is a "starting at", and nothing on the site says whether a 2.5 mg month and a 15 mg month cost the same. A posted price you can read before signing up is genuinely better than a quiz. It still is not an answer to the only question this article is about, which is what month twelve costs.

There is a fifth shape, and it is the one that catches careful readers. Amble says "Same price, every dose" — the exact promise this article tells you to look for. Two things undercut it. The flat-dose line is a promotion that, in Amble's own safety copy, "expires within 24 hours of any price updates". And the advertised $179 is the semaglutide price only: Amble's intake catalog prices tirzepatide at $329 a month, 84% higher, and that ladder appears on no page you can read before starting the questionnaire. Effecty has the cleanest version of the promise — "same dose pricing for all GLP-1 medications and there is no membership fee" — but its cheap rungs are prepaid blocks quoted as monthly figures, so the advertised $145 a month is $1,740 on the day you sign up. Flat at every dose and flat on your bank statement are two different claims, and both of these providers pass the first while failing the second.

A sixth shape belongs in this article too: the membership-plus-protocol stack. Primary Clinic (Direct GLP) requires an $89/mo Direct Primary Care membership before its wholesale GLP-1 dosing ladder even applies — $174/mo all-in at the lowest semaglutide tier, rising as you titrate up. Regenics runs the same shape at a flat per-molecule rate: a mandatory $79/mo membership plus a $249/mo semaglutide protocol or $399/mo tirzepatide protocol, for $328/mo or $478/mo all-in. Neither number is hidden — both are confirmed straight from the provider's own bundle or public API — but neither site prints the combined figure on its own homepage. Add the two line items yourself before you compare either one to a genuinely flat program above.

A 12-month cost illustration

Numbers below are illustrative examples only — not any specific provider's pricing — to show the shape of the two curves. Confirm real figures with each program before deciding.

Say a flat program charges an illustrative $250 every month. Twelve months is a flat $3,000, and you knew that on day one.

Now a dose-scaling program that opens at an illustrative $200 but rises with each titration step: perhaps $200 for the first two months, $275 for the next three, $350 for the next three, and $425 for the final four as you reach maintenance. That path totals roughly $4,075 across the year — over a thousand dollars more than the flat option — even though its advertised starting price looked lower. The cheaper headline was the most expensive plan.

The lesson is not the exact dollars. It is that a lower starting price under dose-scaling tells you almost nothing about the twelve-month total, while a flat price tells you everything.

Maintenance means this compounds

This is not a one-year decision you make once and forget. GLP-1 benefits depend on staying on treatment. When people stopped semaglutide in the STEP 4 trial, weight came back³, and the SURMOUNT-4 trial showed the same pattern with tirzepatide — continuing treatment maintained the loss, stopping reversed it⁴. Realistically you are budgeting for many months, likely years. A pricing model that drifts upward does not just cost more this year; it compounds every year you stay on, which is the whole point of the medication.

The decisive rule

For predictability, choose flat. A single monthly number you can put in a household budget beats a lower headline that escalates precisely as the drug starts working. If two programs are otherwise comparable on clinical oversight and product sourcing, let the flat-price one win on cost certainty alone. The cheapest GLP-1 board applies that test to the whole roster, priced at a maintenance dose over twelve months rather than at the sticker.

A genuinely flat price is rarer than the marketing suggests. TeleHealth Med states one number with "no membership costs, no hidden fees, same price all" — a real flat structure, verified directly on its signup app. Joey Med, by contrast, headlines a lower first-fill price ($199/$275) with the actual standing rate ($279/$399) printed smaller underneath — dose-scaling's sibling trap, a promo-to-standard step-up instead of a dose-driven one. Invyncible shows every price as a permanent "sale" against a higher reference figure that never seems to expire, and Green Cap Health publishes only a first-month rate with no disclosed month-two price at all — arguably the least predictable structure checked this round, since there's no second number to even compare against.

Confirm current pricing directly, then make the final call with a clinician who can see your whole picture.